Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Furin

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
The Lancet. Global Health|September 16, 2022
Household contact management for rifampicin-resistant tuberculosisAnja Reuter, Ivy Apolisi, Johnny Daniels, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|July 19, 2011
The role of the nurse in implementation of an HIV treatment program in rural LesothoJennifer Furin, Mona Haidar, Nicolas Lesia, et al.
The Lancet. Respiratory Medicine|November 14, 2018
Revising the definition of extensively drug-resistant tuberculosisChristoph Lange, Dumitru Chesov, Jennifer Furin, et al.
BMC Health Services Research|January 23, 2025
Navigating DR-TB Treatment care: a qualitative exploration of barriers and facilitators to retention in care among people with history of early disengagement from drug-resistant tuberculosis treatment in Johannesburg, South AfricaNdiviwe Mphothulo, Sindisiwe Hlangu, Jennifer Furin, et al.
BMC Infectious Diseases|August 13, 2024
'Not taking medications and taking medication, it was the same thing:' perspectives of antiretroviral therapy among people hospitalised with advanced HIV diseaseMarian Loveday, Sindisiwe Hlangu, Pariva Manickchund, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Pan-tuberculosis regimens: an argument againstKeertan Dheda, Tawanda Gumbo, Christoph Lange, et al.
The Lancet. Infectious Diseases|March 27, 2019
The STREAM trial: missed opportunities and lessons for future clinical trialsMarian Loveday, Anja Reuter, Jennifer Furin, et al.
The Lancet. Infectious Diseases|October 14, 2015
Compassionate and optimum use of new tuberculosis drugsCaitlin Reed, Leona Mason, Helen Cox, et al.
Lancet (London, England)|October 31, 2015
No one with HIV should die from tuberculosisJennifer Furin, Paula Akugizibwe, Lucica Ditiu, et al.
Plos One|December 30, 2015
Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?Stella Benbaba, Petros Isaakidis, Mrinalini Das, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
The Lancet. Global Health|September 16, 2022
Household contact management for rifampicin-resistant tuberculosisAnja Reuter, Ivy Apolisi, Johnny Daniels, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|July 19, 2011
The role of the nurse in implementation of an HIV treatment program in rural LesothoJennifer Furin, Mona Haidar, Nicolas Lesia, et al.
The Lancet. Respiratory Medicine|November 14, 2018
Revising the definition of extensively drug-resistant tuberculosisChristoph Lange, Dumitru Chesov, Jennifer Furin, et al.
BMC Health Services Research|January 23, 2025
Navigating DR-TB Treatment care: a qualitative exploration of barriers and facilitators to retention in care among people with history of early disengagement from drug-resistant tuberculosis treatment in Johannesburg, South AfricaNdiviwe Mphothulo, Sindisiwe Hlangu, Jennifer Furin, et al.
BMC Infectious Diseases|August 13, 2024
'Not taking medications and taking medication, it was the same thing:' perspectives of antiretroviral therapy among people hospitalised with advanced HIV diseaseMarian Loveday, Sindisiwe Hlangu, Pariva Manickchund, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Pan-tuberculosis regimens: an argument againstKeertan Dheda, Tawanda Gumbo, Christoph Lange, et al.
The Lancet. Infectious Diseases|March 27, 2019
The STREAM trial: missed opportunities and lessons for future clinical trialsMarian Loveday, Anja Reuter, Jennifer Furin, et al.
The Lancet. Infectious Diseases|October 14, 2015
Compassionate and optimum use of new tuberculosis drugsCaitlin Reed, Leona Mason, Helen Cox, et al.
Lancet (London, England)|October 31, 2015
No one with HIV should die from tuberculosisJennifer Furin, Paula Akugizibwe, Lucica Ditiu, et al.
Plos One|December 30, 2015
Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?Stella Benbaba, Petros Isaakidis, Mrinalini Das, et al.
Pageof 16